Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers seeds for cereals, such as maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, including cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green paeas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements, such as WINPro GOLii, WINall, and Win Chi Win growth enhancer; and forage supplements, including NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The company offers its products through a network of distributors, dealers, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.

Nath Bio-Genes (India) Limited

Innoterra enables the agri-food ecosystem through digital connectivity, connecting Indian retailers and buyers with global farmers and sellers transparently and fairly. It offers tech-based solutions for various agricultural sectors, including dairy, food products, and bioscience.

Innoterra

Nath Bio-Genes (I) Ltd. is involved in the development and production of seeds for agriculture, focusing on high-quality products and research to improve farmer productivity.

Nath Bio-Genes (I) Ltd.

Nath Bio-Genes (India) Limited | 5,307 followers on LinkedIn. हर बीज खरा, शक्ती भरा !! | Nath Bio- Genes (I) Ltd, amongst the top players in the Indian seed industry, has served Indian farmers for more than four decades. The company has played a pivotal role in shaping Indian agriculture by developing and supplying quality hybrids seeds to farmers. The company has a presence in 17 over states and markets approximately 150 varieties of seed products to more than 5 million farmers across the country.

Metric
Company Name	Nath Bio-Genes (India) Limited	Innoterra
Symbol	NATHBIOGEN
MSH ID	COM:NATHBIOGENES	COM:INNOTERRA
Market	STOCKS	PRIVATE
Sector	Basic Materials	Consumer Services
Industry	Agricultural Inputs	Agri-tech
Country	IN	IN
Stage		Grant
Employee Count	433
Website	nathbiogenes.com	innoterra.com
LinkedIn	nathbiogenes	innoterra
Founders

Metric
Market Cap	56.06M
Enterprise Value
Monthly Web Traffic		1.35K
Web Traffic Growth		0.72
Valuation
Raised Capital		6.30M

Metric
Revenue	39.27M
Revenue (LTM)
Revenue (NTM)
Gross Profit	19.78M
EBITDA	5.89M
Operating Income	5.50M
Net Income	4.68M
EPS	0.25
Diluted EPS	0.25
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.58
Operating Profit Margin	0.15
EBITDA Margin	0.15
Net Profit Margin	0.12
Return on Equity	0.14
Return on Assets	0.05
Return on Capital Employed	0.08

COM:NATHBIOGENES

Nath Bio-Genes (I) Ltd.

Last Close

163.12

14/02 09:59

Market Cap

4.75B

Beta: -

Volume Today

13.88K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	9.81
P/B Ratio	0.66
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.47
EV Multiple	8.77

Metric
Days Sales Outstanding	245.17
Days Payables Outstanding	43.12
Days Inventory Outstanding	599.37
Operating Cycle	702.86
Cash Conversion Cycle	590.18
Asset Turnover	0.39

Metric
Operating Cash Flow	7.26M
Free Cash Flow	6.27M
Cash Flow to Debt	0.04
Operating Cash Flow/Sales	0.02
Free Cash Flow Yield

Metric
Cash & Equivalents	9.14M
Accounts Receivable	326.42K
Inventory	27.19M
Goodwill
Debt to Capitalization	0.15
Debt to Assets	0.13
Current Ratio	2.40
Quick Ratio	1.30

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue